fbpx

A Cancer Treatment Causes Side Effect of Night Vision

Research published in the Journal of Physical Chemistry Letters explained why photodynamic cancer therapy causes night vision in patients. Photodynamic therapy is a form of cancer treatment that uses light to destroy malignant cells. The interesting side effect patients have reported is night vision seen as silhouettes and outlines in the dark. Only now have researchers discovered the mechanics of this phenomenon.

The Mechanics of Night Vision

Photodynamic therapy involves injections of chlorin e6, a photosensitive compound. It’s the reaction between chlorin e6 and rhodopsin in the retinal photoreceptors rods that causes the apparent night vision to occur. Normally we see with visible light because of a compound in our eye called retinal being triggered by visible light. After triggering, retinal separates from rhodopsin, a light-sensitive protein in the retinas of our eyes, and an electrical signal is transmitted to our brain to interpret what we see. In the case of night vision seen by these cancer patients, infrared light combined with the chlorin e6 changes retinal in the same way it does under visible light conditions. “This explains the increase in night-time visual acuity,” chemist Antonio Monari, from the University of Lorraine in France tells CNRS (French National Centre for Scientific Research).

Using Molecular Simulation to Understand Chemical Reactions

The researchers used molecular simulation to model the movements of individual atoms as well as the breaking or creating of chemical bonds. It took several months of testing various simulations with millions of calculations before it was able to accurately model the chemical reaction caused by infrared radiation. “For our simulation we placed a virtual rhodopsin protein inserted in its lipid membrane in contact with several chlorin e6 molecules and water, or several tens of thousands of atoms,” Monari told CNRS.

Molecular simulation is a powerful tool and can help us better understand fundamental mechanisms. For example, it can help understand why certain DNA lesions are better repaired than others and help select the best therapeutic molecules by mimicking their interaction in a simulated model.

Reference: https://www.sciencealert.com/scientists-have-figured-out-how-a-cancer-treatment-gives-patients-night-vision

Featured Posts

Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read more
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read more
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read more
Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read More
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read More
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read More
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read More
Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read more
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read more
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read more
Vision Expo new logo

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More
EssilorLuxottica

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

Read more
JF Rey Collection Femme Dec 2025

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

Read more
Opti Munich 2026 logo

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Read more